Organon & Co. (OGN)

NYSE

$13.76

$+0.02

(+0.11%)

Previous Close: ⁦$13.75⁩

Market Closed

Organon & Co. (OGN) Live Price Chart

Last updated: ⁦2026-10-24 06:03:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Organon & Co. (OGN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $13.76, with a market capitalization of $3.61B and a P/E ratio of 17.28. Over the past 52 weeks, its price has ranged from $5.69 to $13.83. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$3.61B
Open	$13.74
Day's High	$39.48
Day's Low	$5.69
Previous Close	$13.75
Volume	796.87K
Average Volume	2.62M
P/E Ratio	17.28
52-Week High	$13.83
52-Week Low	$5.69
Dividend Yield	0.50%
Earnings Date	--

Organon & Co. (OGN) Latest Closing Stock Price

Organon & Co. (OGN) last closed at $13.75 as of 2026-10-23 23:31:00, unchanged from the previous close of $13.75.

During the latest regular trading session, OGN traded between $5.69 and $39.48, with a volume of 796.87K shares. The closing price was near the lower end and near the upper end of its 52-week range.

Organon & Co. (OGN) 7-Day Stock Price Change

Over the past seven days, Organon & Co. (OGN) moved from $13.74 to $13.76, representing a gain of 0.11% ($0.02).

The stock traded between $13.72 and $13.80 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.

The average daily volume was 2.48 million shares, up versus the previous seven-day period, indicating higher trading activity.

OGN 52-Week Price Position

Position in Range: 99.1%

52W Low$5.69

52W High$13.83

OGN is currently trading at $13.76, placing it 99.1% of the way from its 52-week low of $5.69 to its 52-week high of $13.83. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Organon & Co. (OGN)?

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Organon & Co. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	10000
Exchange	NYSE
Company Website	https://www.organon.com

How to Buy Organon & Co. (OGN) Stock on MEXC

Eligible investors can buy real shares of Organon & Co. (OGN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for OGN and Place Your Order

Open the RealStocks trading page and search for OGN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Organon & Co. (OGN) stock price today?

Organon & Co. (OGN) is currently trading at $ 13.76, up 0.04% ($0.01) from the previous close of $ 13.75. Intraday prices update in real time during regular trading hours.

2.Is OGN stock going up or down today?

As of 2026-10-23 23:31:00, OGN is trading at $ 13.76, up 0.04% ($0.01) from its previous close of $ 13.75. The stock has traded between $ 5.69 and $ 39.48 during today’s regular session. Past price movements do not guarantee future results.

3.What is OGN pre-market price?

As of 2026-10-23 23:31:00, OGN is trading at $ 13.74 in pre-market trading, down 0.07% ($0.01) from the previous close of $ 13.75. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is OGN after-hours price?

As of 2026-10-23 23:31:00, OGN is trading at $ 13.76 in after-hours trading, up 0.07% ($0.01) from the regular-session close of $ 13.75. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is OGN stock trading now?

OGN trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does OGN sit relative to its 52-week high and low?

Over the past 52 weeks, OGN has traded between a low of $ 5.69 and a high of $ 13.83. At $ 13.76, the stock is positioned 99.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Organon & Co. in?

Organon & Co. (OGN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Organon & Co.'s market capitalization and where is it listed?

Organon & Co. is listed on the NYSE exchange with a market capitalization of $ 3.61B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is OGN valued in terms of P/E ratio and EPS?

OGN trades at a P/E ratio of 17.28, based on trailing-twelve-month EPS of $ 0.80. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Organon & Co. pay a dividend?

Organon & Co. pays an indicated annual cash dividend of $ 0.07 per share, with a current dividend yield of 0.50% based on the latest share price. Dividend policies are subject to change at the board's discretion.